Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,258
Closed -$273K 51
2018
Q1
$273K Sell
5,258
-31,518
-86% -$1.7M 0.25% 45
2017
Q4
$1.98M Sell
36,776
-31,176
-46% -$1.73M 1.69% 23
2017
Q3
$4.15M Buy
67,952
+1,146
+2% +$69.5K 3.71% 13
2017
Q2
$4.08M Buy
66,806
+453
+0.7% +$27.6K 3.61% 10
2017
Q1
$4.02M Buy
66,353
+1,309
+2% +$79.4K 3.59% 6
2016
Q4
$3.65M Buy
+65,044
New +$3.81M 3.52% 7

Other funds holding MRK

Lincoln Capital Corp's MRK Position: Q2 2018 in Review

Lincoln Capital Corp sold out of Merck (MRK) in Q2 2018, closing a stake of 5,258 shares — an estimated $273K sold.

Lincoln Capital Corp first reported a position in MRK in Q4 2016 and held it in 6 quarters. The position peaked at $4.15M in Q3 2017. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

  • Lincoln Capital Corp reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
  • Lincoln Capital Corp sold 5,258 Merck shares in Q2 2018, an estimated $273K.
  • Lincoln Capital Corp first reported a position in Merck in Q4 2016 and held it in 6 quarters.
  • Lincoln Capital Corp's Merck position peaked at $4.15M in Q3 2017.
  • 2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Lincoln Capital Corp's 13F filing for Q2 2018, filed 26 Jul 2018.